{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,8]],"date-time":"2026-10-08T04:20:17Z","timestamp":1791433217257,"version":"4.3.3"},"reference-count":77,"publisher":"Springer Science and Business Media LLC","issue":"8","license":[{"start":{"date-parts":[[2019,7,1]],"date-time":"2019-07-01T00:00:00Z","timestamp":1561939200000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2019,7,1]],"date-time":"2019-07-01T00:00:00Z","timestamp":1561939200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Curr Psychiatry Rep"],"published-print":{"date-parts":[[2019,8]]},"DOI":"10.1007\/s11920-019-1051-y","type":"journal-article","created":{"date-parts":[[2019,7,1]],"date-time":"2019-07-01T02:02:47Z","timestamp":1561946567000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":52,"title":["Obsessive-Compulsive Symptoms in Schizophrenia: an Up-To-Date Review of Literature"],"prefix":"10.1007","volume":"21","author":[{"given":"Chlo\u00e9","family":"Tezenas du Montcel","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Antoine","family":"Pelissolo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Franck","family":"Sch\u00fcrhoff","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Baptiste","family":"Pignon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2019,7,1]]},"reference":[{"key":"1051_CR1","doi-asserted-by":"publisher","first-page":"89","DOI":"10.1017\/ipm.2017.7","volume":"35","author":"JR Kelly","year":"2018","unstructured":"Kelly JR, Clarke G, Cryan JF, Dinan TG. Dimensional thinking in psychiatry in the era of the research domain criteria (RDoC). Ir J Psychol Med. 2018;35:89\u201394.","journal-title":"Ir J Psychol Med"},{"key":"1051_CR2","doi-asserted-by":"publisher","first-page":"946","DOI":"10.1093\/schbul\/sbu112","volume":"40","author":"M Leboyer","year":"2014","unstructured":"Leboyer M, Schurhoff F. Searching across diagnostic boundaries. Schizophr Bull. 2014;40:946\u20138.","journal-title":"Schizophr Bull"},{"key":"1051_CR3","unstructured":"Westphal K. \u00dcber Zwangsvorstellungen. Archiv fur Psychiatr und Nervenkr. 1878;8:734\u2013750."},{"key":"1051_CR4","doi-asserted-by":"publisher","first-page":"661","DOI":"10.1192\/bjp.149.5.661","volume":"149","author":"M Bleuler","year":"1986","unstructured":"Bleuler M, Bleuler R. Dementia praecox oder die Gruppe der Schizophrenien: Eugen Bleuler. Br J Psychiatry. 1986;149:661\u20134.","journal-title":"Br J Psychiatry"},{"key":"1051_CR5","doi-asserted-by":"crossref","unstructured":"Janet P, Raymond F. Les obsessions et la psychast\u00e9nie. Vol. 2. Paris: Felix Alcan; 1903.","DOI":"10.2307\/1412725"},{"key":"1051_CR6","doi-asserted-by":"publisher","first-page":"19","DOI":"10.1097\/HRP.0000000000000027","volume":"23","author":"L Attademo","year":"2015","unstructured":"Attademo L, Bernardini F, Paolini E, Quartesan R. History and conceptual problems of the relationship between obsessions and hallucinations. Harv Rev Psychiatry. 2015;23:19\u201327.","journal-title":"Harv Rev Psychiatry"},{"key":"1051_CR7","doi-asserted-by":"publisher","first-page":"811","DOI":"10.1093\/schbul\/sbp148","volume":"37","author":"AM Achim","year":"2011","unstructured":"Achim AM, Maziade M, Raymond E, Olivier D, M\u00e9rette C, Roy M-A. How prevalent are anxiety disorders in schizophrenia? A meta-analysis and critical review on a significant association. Schizophr Bull. 2011;37:811\u201321.","journal-title":"Schizophr Bull"},{"key":"1051_CR8","doi-asserted-by":"publisher","first-page":"327","DOI":"10.1016\/j.pnpbp.2005.11.001","volume":"30","author":"LF Fontenelle","year":"2006","unstructured":"Fontenelle LF, Mendlowicz MV, Versiani M. The descriptive epidemiology of obsessive-compulsive disorder. Prog Neuro-Psychopharmacol Biol Psychiatry. 2006;30:327\u201337.","journal-title":"Prog Neuro-Psychopharmacol Biol Psychiatry"},{"key":"1051_CR9","doi-asserted-by":"publisher","first-page":"458","DOI":"10.1016\/j.schres.2013.10.033","volume":"152","author":"M Swets","year":"2014","unstructured":"Swets M, Dekker J, van Emmerik-van Oortmerssen K, Smid GE, Smit F, de Haan L, et al. The obsessive compulsive spectrum in schizophrenia, a meta-analysis and meta-regression exploring prevalence rates. Schizophr Res. 2014;152:458\u201368.","journal-title":"Schizophr Res"},{"key":"1051_CR10","first-page":"106","volume":"47","author":"L Attademo","year":"2012","unstructured":"Attademo L, De Giorgio G, Quartesan R, Moretti P. Schizophrenia and obsessive-compulsive disorder: from comorbidity to schizo-obsessive disorder. Riv Psichiatr. 2012;47:106\u201315.","journal-title":"Riv Psichiatr"},{"key":"1051_CR11","first-page":"187","volume":"30","author":"A Bottas","year":"2005","unstructured":"Bottas A, Cooke RG, Richter MA. Comorbidity and pathophysiology of obsessive-compulsive disorder in schizophrenia: is there evidence for a schizo-obsessive subtype of schizophrenia? J Psychiatry Neurosci JPN. 2005;30:187\u201393.","journal-title":"J Psychiatry Neurosci JPN"},{"key":"1051_CR12","doi-asserted-by":"publisher","first-page":"989","DOI":"10.2165\/00023210-200418140-00004","volume":"18","author":"M Poyurovsky","year":"2004","unstructured":"Poyurovsky M, Weizman A, Weizman R. Obsessive-compulsive disorder in schizophrenia. CNS Drugs. 2004;18:989\u20131010.","journal-title":"CNS Drugs"},{"key":"1051_CR13","doi-asserted-by":"publisher","first-page":"1076","DOI":"10.1093\/schbul\/sbu169","volume":"41","author":"M Cederl\u00f6f","year":"2015","unstructured":"Cederl\u00f6f M, Lichtenstein P, Larsson H, Boman M, R\u00fcck C, Land\u00e9n M, et al. Obsessive-compulsive disorder, psychosis, and bipolarity: a longitudinal cohort and multigenerational family study. Schizophr Bull. 2015;41:1076\u201383.","journal-title":"Schizophr Bull"},{"key":"1051_CR14","doi-asserted-by":"publisher","first-page":"136","DOI":"10.1111\/j.1600-0447.2010.01609.x","volume":"123","author":"F Van Dael","year":"2011","unstructured":"Van Dael F, van Os J, de Graaf R, ten Have M, Krabbendam L, Myin-Germeys I. Can obsessions drive you mad? Longitudinal evidence that obsessive-compulsive symptoms worsen the outcome of early psychotic experiences. Acta Psychiatr Scand. 2011;123:136\u201346.","journal-title":"Acta Psychiatr Scand"},{"key":"1051_CR15","doi-asserted-by":"publisher","first-page":"1215","DOI":"10.1001\/jamapsychiatry.2014.1011","volume":"71","author":"SM Meier","year":"2014","unstructured":"Meier SM, Petersen L, Pedersen MG, Arendt MCB, Nielsen PR, Mattheisen M, et al. Obsessive-compulsive disorder as a risk factor for schizophrenia: a nationwide study. JAMA Psychiatry. 2014;71:1215\u201321.","journal-title":"JAMA Psychiatry"},{"key":"1051_CR16","doi-asserted-by":"publisher","first-page":"62","DOI":"10.1016\/j.schres.2010.10.017","volume":"125","author":"B Nelson","year":"2011","unstructured":"Nelson B, Yuen K, Yung AR. Ultra high risk (UHR) for psychosis criteria: are there different levels of risk for transition to psychosis? Schizophr Res. 2011;125:62\u20138.","journal-title":"Schizophr Res"},{"key":"1051_CR17","doi-asserted-by":"publisher","first-page":"113","DOI":"10.1001\/jamapsychiatry.2015.2324","volume":"73","author":"P Fusar-Poli","year":"2016","unstructured":"Fusar-Poli P, Cappucciati M, Borgwardt S, Woods SW, Addington J, Nelson B, et al. Heterogeneity of psychosis risk within individuals at clinical high risk: a meta-analytical stratification. JAMA Psychiatry. 2016;73:113\u201320.","journal-title":"JAMA Psychiatry."},{"key":"1051_CR18","doi-asserted-by":"publisher","first-page":"964","DOI":"10.1080\/j.1440-1614.2005.01714.x","volume":"39","author":"AR Yung","year":"2005","unstructured":"Yung AR, Yuen HP, McGorry PD, Phillips LJ, Kelly D, Dell\u2019Olio M, et al. Mapping the onset of psychosis: the comprehensive assessment of at-risk mental states. Aust N Z J Psychiatry. 2005;39:964\u201371.","journal-title":"Aust N Z J Psychiatry."},{"key":"1051_CR19","doi-asserted-by":"publisher","first-page":"1140","DOI":"10.1016\/j.jpsychires.2011.03.005","volume":"45","author":"LF Fontenelle","year":"2011","unstructured":"Fontenelle LF, Lin A, Pantelis C, Wood SJ, Nelson B, Yung AR. A longitudinal study of obsessive-compulsive disorder in individuals at ultra-high risk for psychosis. J Psychiatr Res. 2011;45:1140\u20135.","journal-title":"J Psychiatr Res"},{"key":"1051_CR20","first-page":"283","volume":"36","author":"I \u0141ucka","year":"2002","unstructured":"\u0141ucka I, Fryze M, Cebella A, Staszewska E. Prodromal symptoms of schizophrenics syndrome in children and adolescent. Psychiatr Pol. 2002;36:283\u20136.","journal-title":"Psychiatr Pol"},{"key":"1051_CR21","doi-asserted-by":"publisher","first-page":"480","DOI":"10.1016\/j.comppsych.2011.08.009","volume":"53","author":"M Poyurovsky","year":"2012","unstructured":"Poyurovsky M, Zohar J, Glick I, Koran LM, Weizman R, Tandon R, et al. Obsessive-compulsive symptoms in schizophrenia: implications for future psychiatric classifications. Compr Psychiatry. 2012;53:480\u20133.","journal-title":"Compr Psychiatry"},{"key":"1051_CR22","doi-asserted-by":"publisher","first-page":"170","DOI":"10.1016\/j.schres.2008.11.023","volume":"108","author":"TA Niendam","year":"2009","unstructured":"Niendam TA, Berzak J, Cannon TD, Bearden CE. Obsessive compulsive symptoms in the psychosis prodrome: correlates of clinical and functional outcome. Schizophr Res. 2009;108:170\u20135.","journal-title":"Schizophr Res"},{"key":"1051_CR23","doi-asserted-by":"publisher","first-page":"151","DOI":"10.1093\/schbul\/sbr077","volume":"39","author":"L de Haan","year":"2013","unstructured":"de Haan L, Sterk B, Wouters L, Linszen DH. The 5-year course of obsessive-compulsive symptoms and obsessive-compulsive disorder in first-episode schizophrenia and related disorders. Schizophr Bull. 2013;39:151\u201360.","journal-title":"Schizophr Bull"},{"key":"1051_CR24","doi-asserted-by":"publisher","first-page":"156","DOI":"10.1186\/1471-244X-13-156","volume":"13","author":"K Hagen","year":"2013","unstructured":"Hagen K, Hansen B, Joa I, Larsen TK. Prevalence and clinical characteristics of patients with obsessive-compulsive disorder in first-episode psychosis. BMC Psychiatry. 2013;13:156.","journal-title":"BMC Psychiatry."},{"key":"1051_CR25","doi-asserted-by":"publisher","first-page":"765","DOI":"10.1097\/NMD.0b013e318142ce67","volume":"195","author":"M Poyurovsky","year":"2007","unstructured":"Poyurovsky M, Faragian S, Kleinman-Balush V, Pashinian A, Kurs R, Fuchs C. Awareness of illness and insight into obsessive-compulsive symptoms in schizophrenia patients with obsessive-compulsive disorder. J Nerv Ment Dis. 2007;195:765\u20138.","journal-title":"J Nerv Ment Dis"},{"key":"1051_CR26","doi-asserted-by":"publisher","first-page":"896","DOI":"10.1016\/j.comppsych.2013.12.016","volume":"55","author":"ML Jacob","year":"2014","unstructured":"Jacob ML, Larson MJ, Storch EA. Insight in adults with obsessive-compulsive disorder. Compr Psychiatry. 2014;55:896\u2013903.","journal-title":"Compr Psychiatry"},{"key":"1051_CR27","doi-asserted-by":"publisher","first-page":"352","DOI":"10.1016\/j.jad.2012.01.017","volume":"138","author":"AV Cherian","year":"2012","unstructured":"Cherian AV, Narayanaswamy JC, Srinivasaraju R, Viswanath B, Math SB, Kandavel T, et al. Does insight have specific correlation with symptom dimensions in OCD? J Affect Disord. 2012;138:352\u20139.","journal-title":"J Affect Disord"},{"key":"1051_CR28","doi-asserted-by":"publisher","first-page":"323","DOI":"10.1016\/j.pnpbp.2009.12.007","volume":"34","author":"F Catapano","year":"2010","unstructured":"Catapano F, Perris F, Fabrazzo M, Cioffi V, Giacco D, De Santis V, et al. Obsessive-compulsive disorder with poor insight: a three-year prospective study. Prog Neuro-Psychopharmacol Biol Psychiatry. 2010;34:323\u201330.","journal-title":"Prog Neuro-Psychopharmacol Biol Psychiatry"},{"key":"1051_CR29","first-page":"11","volume":"25","author":"JM Fontenelle","year":"2013","unstructured":"Fontenelle JM, Harrison BJ, Santana L, Concei\u00e7\u00e3o do Ros\u00e1rio M, Versiani M, Fontenelle LF. Correlates of insight into different symptom dimensions in obsessive-compulsive disorder. Ann Clin Psychiatry. 2013;25:11\u20136.","journal-title":"Ann Clin Psychiatry"},{"key":"1051_CR30","doi-asserted-by":"publisher","first-page":"50","DOI":"10.5498\/wjp.v3.i3.50","volume":"3","author":"P Oulis","year":"2013","unstructured":"Oulis P, Konstantakopoulos G, Lykouras L, Michalopoulou PG. Differential diagnosis of obsessive-compulsive symptoms from delusions in schizophrenia: a phenomenological approach. World J Psychiatry. 2013;3:50\u20136.","journal-title":"World J Psychiatry"},{"key":"1051_CR31","doi-asserted-by":"publisher","first-page":"107","DOI":"10.1017\/S1461145704004675","volume":"8","author":"NA Fineberg","year":"2005","unstructured":"Fineberg NA, Gale TM. Evidence-based pharmacotherapy of obsessive-compulsive disorder. Int J Neuropsychopharmacol. 2005;8:107\u201329.","journal-title":"Int J Neuropsychopharmacol"},{"key":"1051_CR32","doi-asserted-by":"publisher","first-page":"70","DOI":"10.4088\/JCP.07r03618","volume":"70","author":"R Cunill","year":"2009","unstructured":"Cunill R, Castells X, Simeon D. Relationships between obsessive-compulsive symptomatology and severity of psychosis in schizophrenia: a systematic review and meta-analysis. J Clin Psychiatry. 2009;70:70\u201382.","journal-title":"J Clin Psychiatry."},{"key":"1051_CR33","doi-asserted-by":"publisher","first-page":"243","DOI":"10.1097\/WNF.0000000000000248","volume":"40","author":"B Baytunca","year":"2017","unstructured":"\u2022 Baytunca B, Kalyoncu T, Ozel I, Erermi\u015f S, Kayahan B, \u00d6ngur D. Early onset schizophrenia associated with obsessive-compulsive disorder: clinical features and correlates. Clin Neuropharmacol. 2017;40:243\u20135. In a retrospective chart review of 29 patients with early onset SZ (10 with OCS\/SZ, 19 SZ), patients suffering from SZ\/OCS received significantly higher doses of antipsychotics during the first episode and at assessment (no sociodemographic differences, similar duration of illnesses and had comparable severity scores on PANSS).","journal-title":"Clin Neuropharmacol"},{"key":"1051_CR34","doi-asserted-by":"publisher","first-page":"111","DOI":"10.1097\/PRA.0000000000000131","volume":"22","author":"M Tonna","year":"2016","unstructured":"\u2022 Tonna M, Ottoni R, Paglia F, Monici A, Ossola P, DE Panfilis C, et al. Obsessive-compulsive symptoms in schizophrenia and in obsessive-compulsive disorder: differences and similarities. J Psychiatr Pract. 2016;22:111\u20136. In this clinical study of the content of obsessions and compulsions in 66 patients suffering from SZ\/OCD (n= 35) or OCD (n=31), OCD patients had a greater level of distress for obsession and compulsion, and obsessive ideas were more aggressive, contamination-related, sexual and somatic obsession in the OCD group than in the SZ group. Patients had similar severity levels, and no association were found between OCS severity and PANSS scores, but delusional symptoms were positively associated with the presence of washing compulsion and hoarding obsession.","journal-title":"J Psychiatr Pract"},{"key":"1051_CR35","doi-asserted-by":"publisher","first-page":"50","DOI":"10.1016\/j.psychres.2015.07.089","volume":"230","author":"AG Szmulewicz","year":"2015","unstructured":"Szmulewicz AG, Smith JM, Valerio MP. Suicidality in clozapine-treated patients with schizophrenia: role of obsessive-compulsive symptoms. Psychiatry Res. 2015;230:50\u20135.","journal-title":"Psychiatry Res"},{"key":"1051_CR36","doi-asserted-by":"publisher","first-page":"201","DOI":"10.1016\/0920-9964(92)90003-N","volume":"6","author":"D Addington","year":"1992","unstructured":"Addington D, Addington J, Maticka-Tyndale E, Joyce J. Reliability and validity of a depression rating scale for schizophrenics. Schizophr Res. 1992;6:201\u20138.","journal-title":"Schizophr Res"},{"key":"1051_CR37","doi-asserted-by":"publisher","first-page":"437","DOI":"10.1176\/ajp.143.10.1323-a","volume":"143","author":"WS Fenton","year":"1986","unstructured":"Fenton WS, McGlashan TH. The prognostic significance of obsessive-compulsive symptoms in schizophrenia. Am J Psychiatry. 1986;143:437\u201341.","journal-title":"Am J Psychiatry"},{"key":"1051_CR38","doi-asserted-by":"publisher","first-page":"161","DOI":"10.1177\/0004867411432851","volume":"46","author":"J-W Hur","year":"2012","unstructured":"Hur J-W, Shin NY, Jang JH, Shim G, Park HY, Hwang JY, et al. Clinical and neurocognitive profiles of subjects at high risk for psychosis with and without obsessive-compulsive symptoms. Aust N Z J Psychiatry. 2012;46:161\u20139.","journal-title":"Aust N Z J Psychiatry"},{"key":"1051_CR39","doi-asserted-by":"publisher","first-page":"5","DOI":"10.1016\/j.schres.2004.09.010","volume":"72","author":"SR Marder","year":"2004","unstructured":"Marder SR, Fenton W. Measurement and treatment research to improve cognition in schizophrenia: NIMH MATRICS initiative to support the development of agents for improving cognition in schizophrenia. Schizophr Res. 2004;72:5\u20139.","journal-title":"Schizophr Res"},{"key":"1051_CR40","doi-asserted-by":"publisher","first-page":"1290","DOI":"10.1093\/schbul\/sbw029","volume":"42","author":"E Bulzacka","year":"2016","unstructured":"Bulzacka E, Boyer L, Sch\u00fcrhoff F, Godin O, Berna F, Brunel L, et al. Chronic peripheral inflammation is associated with cognitive impairment in schizophrenia: results from the multicentric FACE-SZ dataset. Schizophr Bull. 2016;42:1290\u2013302.","journal-title":"Schizophr Bull"},{"key":"1051_CR41","doi-asserted-by":"publisher","first-page":"196","DOI":"10.1016\/j.schres.2018.06.021","volume":"201","author":"P Roux","year":"2018","unstructured":"Roux P, Urbach M, Fonteneau S, Berna F, Brunel L, Capdevielle D, et al. Psychiatric disability as mediator of the neurocognition-functioning link in schizophrenia spectrum disorders: SEM analysis using the evaluation of cognitive processes involved in disability in schizophrenia (ECPDS) scale. Schizophr Res. 2018;201:196\u2013203.","journal-title":"Schizophr Res"},{"key":"1051_CR42","doi-asserted-by":"publisher","first-page":"1015","DOI":"10.1016\/j.comppsych.2013.12.004","volume":"55","author":"PG Michalopoulou","year":"2014","unstructured":"Michalopoulou PG, Konstantakopoulos G, Typaldou M, Papageorgiou C, Christodoulou GN, Lykouras L, et al. Can cognitive deficits differentiate between schizophrenia with and without obsessive-compulsive symptoms? Compr Psychiatry. 2014;55:1015\u201321.","journal-title":"Compr Psychiatry"},{"key":"1051_CR43","doi-asserted-by":"publisher","first-page":"1261","DOI":"10.1093\/schbul\/sbs123","volume":"39","author":"F Schirmbeck","year":"2013","unstructured":"\u2022\u2022 Schirmbeck F, Rausch F, Englisch S, Eifler S, Esslinger C, Meyer-Lindenberg A, et al. Stable cognitive deficits in schizophrenia patients with comorbid obsessive-compulsive symptoms: a 12-month longitudinal study. Schizophr Bull. 2013;39:1261\u201371. In this 6-months longitudinal study of SZ patients (N = 56) and their unaffected siblings (N = 49), higher severity of positive, negative, and depressive symptoms was positively associated with higher concurrent OCS severity across subject and significantly predicted OCS severity 4 weeks later and vice-versa.","journal-title":"Schizophr Bull"},{"key":"1051_CR44","doi-asserted-by":"publisher","first-page":"52","DOI":"10.1016\/j.psychres.2008.11.002","volume":"170","author":"S Pallanti","year":"2009","unstructured":"Pallanti S, Castellini G, Chamberlain SR, Quercioli L, Zaccara G, Fineberg NA. Cognitive event-related potentials differentiate schizophrenia with obsessive-compulsive disorder (schizo-OCD) from OCD and schizophrenia without OC symptoms. Psychiatry Res. 2009;170:52\u201360.","journal-title":"Psychiatry Res"},{"key":"1051_CR45","doi-asserted-by":"publisher","first-page":"233","DOI":"10.1186\/s12888-017-1392-1","volume":"17","author":"K Hagen","year":"2017","unstructured":"\u2022\u2022 Hagen K, Solem S, Opstad HB, Hansen B, Hagen R. The role of metacognition and obsessive-compulsive symptoms in psychosis: an analogue study. BMC Psychiatry. 2017;17:233. Among a non-clinical sample (N = 194), OCS were moderately-strongly correlated with psychotic symptoms (paranoia and hallucinations). OCS and metacognitive dysfunction both showed a significant influence and accounted for important variance on the levels of paranoid ideation and hallucinations.","journal-title":"BMC Psychiatry"},{"key":"1051_CR46","doi-asserted-by":"publisher","first-page":"265","DOI":"10.1017\/S1352465800015873","volume":"23","author":"AP Morrison","year":"1995","unstructured":"Morrison AP, Haddock G, Tarrier N. Intrusive thoughts and auditory hallucinations: a cognitive approach. Behav Cogn Psychother. 1995;23:265\u201380.","journal-title":"Behav Cogn Psychother"},{"key":"1051_CR47","doi-asserted-by":"publisher","first-page":"531","DOI":"10.1080\/13546801003783508","volume":"15","author":"S Moritz","year":"2010","unstructured":"Moritz S, Peters MJV, Lar\u00f8i F, Lincoln TM. Metacognitive beliefs in obsessive-compulsive patients: a comparison with healthy and schizophrenia participants. Cogn Neuropsychiatry. 2010;15:531\u201348.","journal-title":"Cogn Neuropsychiatry"},{"issue":"6","key":"1051_CR48","doi-asserted-by":"publisher","first-page":"364","DOI":"10.4088\/JCP.v60n0603","volume":"60","author":"Lieuwe de Haan","year":"1999","unstructured":"de Haan L, Linszen DH, Gorsira R. Clozapine and obsessions in patients with recent-onset schizophrenia and other psychotic disorders. J Clin Psychiatry 1999;60:364\u2013365.","journal-title":"The Journal of Clinical Psychiatry"},{"key":"1051_CR49","first-page":"439","volume":"53","author":"RW Baker","year":"1992","unstructured":"Baker RW, Chengappa KN, Baird JW, Steingard S, Christ MA, Schooler NR. Emergence of obsessive compulsive symptoms during treatment with clozapine. J Clin Psychiatry. 1992;53:439\u201342.","journal-title":"J Clin Psychiatry."},{"key":"1051_CR50","doi-asserted-by":"publisher","first-page":"119","DOI":"10.1016\/j.psychres.2016.09.031","volume":"246","author":"D Grillault Laroche","year":"2016","unstructured":"Grillault Laroche D, Gaillard A. Induced obsessive compulsive symptoms (OCS) in schizophrenia patients under atypical 2 antipsychotics (AAPs): review and hypotheses. Psychiatry Res. 2016;246:119\u201328.","journal-title":"Psychiatry Res"},{"key":"1051_CR51","doi-asserted-by":"publisher","first-page":"510","DOI":"10.1007\/s11920-014-0510-8","volume":"16","author":"TM Fonseka","year":"2014","unstructured":"Fonseka TM, Richter MA, M\u00fcller DJ. Second generation antipsychotic-induced obsessive-compulsive symptoms in schizophrenia: a review of the experimental literature. Curr Psychiatry Rep. 2014;16:510.","journal-title":"Curr Psychiatry Rep"},{"key":"1051_CR52","doi-asserted-by":"publisher","first-page":"317980","DOI":"10.1155\/2014\/317980","volume":"2014","author":"M Zink","year":"2014","unstructured":"Zink M. Comorbid obsessive-compulsive symptoms in schizophrenia: insight into pathomechanisms facilitates treatment. Adv Med. 2014;2014:317980.","journal-title":"Adv Med"},{"key":"1051_CR53","doi-asserted-by":"crossref","unstructured":"Schirmbeck F, Konijn M, Hoetjes V, Zink M, de Haan L. For genetic risk and outcome of psychosis (GROUP). Obsessive-compulsive symptoms in psychotic disorders: longitudinal associations of symptom clusters on between- and within-subject levels. Eur Arch Psychiatry Clin Neurosci. 2018.","DOI":"10.1007\/s00406-018-0884-4"},{"key":"1051_CR54","doi-asserted-by":"publisher","first-page":"303","DOI":"10.1097\/01.ftd.0000211801.66569.80","volume":"28","author":"S-K Lin","year":"2006","unstructured":"Lin S-K, Su S-F, Pan C-H. Higher plasma drug concentration in clozapine-treated schizophrenic patients with side effects of obsessive\/compulsive symptoms. Ther Drug Monit. 2006;28:303\u20137.","journal-title":"Ther Drug Monit"},{"issue":"Suppl","key":"1051_CR55","doi-asserted-by":"publisher","first-page":"S18","DOI":"10.1007\/BF00442554","volume":"99","author":"HY Meltzer","year":"1989","unstructured":"Meltzer HY. Clinical studies on the mechanism of action of clozapine: the dopamine-serotonin hypothesis of schizophrenia. Psychopharmacology. 1989;99(Suppl):S18\u201327.","journal-title":"Psychopharmacology"},{"key":"1051_CR56","doi-asserted-by":"publisher","first-page":"227","DOI":"10.1097\/WNF.0b013e31819cc8e6","volume":"32","author":"S Englisch","year":"2009","unstructured":"Englisch S, Esslinger C, Inta D, Weinbrenner A, Peus V, Gutschalk A, et al. Clozapine-induced obsessive-compulsive syndromes improve in combination with aripiprazole. Clin Neuropharmacol. 2009;32:227\u20139.","journal-title":"Clin Neuropharmacol"},{"key":"1051_CR57","doi-asserted-by":"publisher","first-page":"1386","DOI":"10.1016\/j.pnpbp.2008.02.010","volume":"32","author":"S Englisch","year":"2008","unstructured":"Englisch S, Zink M. Combined antipsychotic treatment involving clozapine and aripiprazole. Prog Neuro-Psychopharmacol Biol Psychiatry. 2008;32:1386\u201392.","journal-title":"Prog Neuro-Psychopharmacol Biol Psychiatry"},{"key":"1051_CR58","doi-asserted-by":"publisher","first-page":"2668","DOI":"10.1017\/S003329171800017X","volume":"48","author":"E Fernandez-Egea","year":"2018","unstructured":"\u2022\u2022 Fernandez-Egea E, Worbe Y, Bernardo M, Robbins TW. Distinct risk factors for obsessive and compulsive symptoms in chronic schizophrenia. Psychol Med. 2018;48:2668\u201375. In this study of risk factor of clozapine-induced OCS in a sample of clozapine-treated SZ patients (N = 118), 47 % of the sample reached threshold criteria for OCD and were on anti-OCD medication. Length of clozapine treatment was correlated with checking severity and authors showed a direct correlation between OCS and clozapine plasma levels. Patients on polypharmacy had higher OCS scores and higher OCD prevalence.","journal-title":"Psychol Med"},{"key":"1051_CR59","doi-asserted-by":"publisher","first-page":"99","DOI":"10.3389\/fphar.2013.00099","volume":"4","author":"F Schirmbeck","year":"2013","unstructured":"Schirmbeck F, Zink M. Comorbid obsessive-compulsive symptoms in schizophrenia: contributions of pharmacological and genetic factors. Front Pharmacol. 2013;4:99.","journal-title":"Front Pharmacol"},{"key":"1051_CR60","doi-asserted-by":"publisher","first-page":"2361","DOI":"10.1017\/S0033291711000419","volume":"41","author":"F Schirmbeck","year":"2011","unstructured":"Schirmbeck F, Esslinger C, Rausch F, Englisch S, Meyer-Lindenberg A, Zink M. Antiserotonergic antipsychotics are associated with obsessive-compulsive symptoms in schizophrenia. Psychol Med. 2011;41:2361\u201373.","journal-title":"Psychol Med"},{"key":"1051_CR61","doi-asserted-by":"publisher","first-page":"96","DOI":"10.1097\/YIC.0b013e32835bd24e","volume":"28","author":"R Stryjer","year":"2013","unstructured":"Stryjer R, Dambinsky Y, Timinsky I, Green T, Kotler M, Weizman A, et al. Escitalopram in the treatment of patients with schizophrenia and obsessive-compulsive disorder: an open-label, prospective study. Int Clin Psychopharmacol. 2013;28:96\u20138.","journal-title":"Int Clin Psychopharmacol"},{"key":"1051_CR62","doi-asserted-by":"publisher","first-page":"133","DOI":"10.1016\/j.psychres.2007.06.010","volume":"159","author":"M Poyurovsky","year":"2008","unstructured":"Poyurovsky M, Faragian S, Shabeta A, Kosov A. Comparison of clinical characteristics, co-morbidity and pharmacotherapy in adolescent schizophrenia patients with and without obsessive-compulsive disorder. Psychiatry Res. 2008;159:133\u20139.","journal-title":"Psychiatry Res"},{"key":"1051_CR63","doi-asserted-by":"publisher","first-page":"217","DOI":"10.1016\/j.jad.2017.04.068","volume":"218","author":"MA Sugarman","year":"2017","unstructured":"Sugarman MA, Kirsch I, Huppert JD. Obsessive-compulsive disorder has a reduced placebo (and antidepressant) response compared to other anxiety disorders: a meta-analysis. J Affect Disord. 2017;218:217\u201326.","journal-title":"J Affect Disord"},{"issue":"Suppl 14","key":"1051_CR64","first-page":"11","volume":"65","author":"D Denys","year":"2004","unstructured":"Denys D, Zohar J, Westenberg HG. The role of dopamine in obsessive-compulsive disorder: preclinical and clinical evidence. J Clin Psychiatry. 2004;65(Suppl 14):11\u20137.","journal-title":"J Clin Psychiatry."},{"key":"1051_CR65","doi-asserted-by":"publisher","first-page":"103","DOI":"10.1007\/s11920-017-0847-x","volume":"19","author":"B Pignon","year":"2017","unstructured":"Pignon B, Tezenas du Montcel C, Carton L, Pelissolo A. The place of antipsychotics in the therapy of anxiety disorders and obsessive-compulsive disorders. Curr Psychiatry Rep. 2017;19:103.","journal-title":"Curr Psychiatry Rep."},{"key":"1051_CR66","doi-asserted-by":"publisher","first-page":"214","DOI":"10.1097\/JCP.0b013e318166f520","volume":"28","author":"L van Nimwegen","year":"2008","unstructured":"van Nimwegen L, de Haan L, van Beveren N, Laan W, van den Brink W, Linszen D. Obsessive-compulsive symptoms in a randomized, double-blind study with olanzapine or risperidone in young patients with early psychosis. J Clin Psychopharmacol. 2008;28:214\u20138.","journal-title":"J Clin Psychopharmacol"},{"key":"1051_CR67","doi-asserted-by":"publisher","first-page":"819","DOI":"10.1007\/s40263-015-0282-7","volume":"29","author":"H Temmingh","year":"2015","unstructured":"Temmingh H, Stein DJ. Anxiety in patients with schizophrenia: epidemiology and management. CNS Drugs. 2015;29:819\u201332.","journal-title":"CNS Drugs."},{"issue":"Suppl","key":"1051_CR68","first-page":"24","volume":"55","author":"CJ McDougle","year":"1994","unstructured":"McDougle CJ, Goodman WK, Price LH. Dopamine antagonists in tic-related and psychotic spectrum obsessive compulsive disorder. J Clin Psychiatry. 1994;55(Suppl):24\u201331.","journal-title":"J Clin Psychiatry."},{"key":"1051_CR69","doi-asserted-by":"publisher","first-page":"863","DOI":"10.4088\/JCP.08m04369","volume":"70","author":"H Matsunaga","year":"2009","unstructured":"Matsunaga H, Nagata T, Hayashida K, Ohya K, Kiriike N, Stein DJ. A long-term trial of the effectiveness and safety of atypical antipsychotic agents in augmenting SSRI-refractory obsessive-compulsive disorder. J Clin Psychiatry. 2009;70:863\u20138.","journal-title":"J Clin Psychiatry."},{"key":"1051_CR70","doi-asserted-by":"crossref","first-page":"286","DOI":"10.1176\/ajp.156.2.286","volume":"156","author":"S Kapur","year":"1999","unstructured":"Kapur S, Zipursky RB, Remington G. Clinical and theoretical implications of 5-HT2 and D2 receptor occupancy of clozapine, risperidone, and olanzapine in schizophrenia. Am J Psychiatry. 1999;156:286\u201393.","journal-title":"Am J Psychiatry"},{"key":"1051_CR71","doi-asserted-by":"publisher","first-page":"236","DOI":"10.1055\/s-2000-8360","volume":"33","author":"R Ramasubbu","year":"2000","unstructured":"Ramasubbu R, Ravindran A, Lapierre Y. Serotonin and dopamine antagonism in obsessive-compulsive disorder: effect of atypical antipsychotic drugs. Pharmacopsychiatry. 2000;33:236\u20138.","journal-title":"Pharmacopsychiatry."},{"key":"1051_CR72","doi-asserted-by":"crossref","unstructured":"Schirmbeck F, Zink M. Comorbid obsessive-compulsive symptoms in schizophrenia: contributions of pharmacological and genetic factors. Front Pharmacol [Internet] 2013 [cited 2018 Dec 9];4. Available from: https:\/\/www.frontiersin.org\/articles\/10.3389\/fphar.2013.00099\/full . Accessed 09 Jun 2019.","DOI":"10.3389\/fphar.2013.00099"},{"key":"1051_CR73","doi-asserted-by":"publisher","first-page":"375","DOI":"10.1097\/JCP.0b013e31821927d8","volume":"31","author":"V Villari","year":"2011","unstructured":"Villari V, Frieri T, Fagiolini A. Aripiprazole augmentation in clozapine-associated obsessive-compulsive symptoms. J Clin Psychopharmacol. 2011;31:375\u20136.","journal-title":"J Clin Psychopharmacol"},{"key":"1051_CR74","doi-asserted-by":"publisher","first-page":"40","DOI":"10.1186\/1744-859X-12-40","volume":"12","author":"G Ery\u0131lmaz","year":"2013","unstructured":"Ery\u0131lmaz G, H\u0131zl\u0131 Sayar G, Ozten E, G\u00f6gceg\u00f6z G\u00fcl I, Karamustafal\u0131o\u011flu O. Aripirazole augmentation in clozapine-associated obsessive-compulsive symptoms in schizophrenia. Ann General Psychiatry. 2013;12:40.","journal-title":"Ann General Psychiatry"},{"key":"1051_CR75","first-page":"423","volume":"56","author":"FM Jacobsen","year":"1995","unstructured":"Jacobsen FM. Risperidone in the treatment of affective illness and obsessive-compulsive disorder. J Clin Psychiatry. 1995;56:423\u20139.","journal-title":"J Clin Psychiatry."},{"key":"1051_CR76","doi-asserted-by":"publisher","first-page":"367","DOI":"10.1186\/2047-783X-14-8-367","volume":"14","author":"F Hanisch","year":"2009","unstructured":"Hanisch F, Friedemann J, Piro J, Gutmann P. Maintenance electroconvulsive therapy for comorbid pharmacotherapy-refractory obsessive-compulsive and schizoaffective disorder. Eur J Med Res. 2009;14:367\u20138.","journal-title":"Eur J Med Res"},{"key":"1051_CR77","doi-asserted-by":"publisher","first-page":"449","DOI":"10.5498\/wjp.v6.i4.449","volume":"6","author":"A Tundo","year":"2016","unstructured":"Tundo A, Necci R. Cognitive-behavioural therapy for obsessive-compulsive disorder co-occurring with psychosis: systematic review of evidence. World J Psychiatry. 2016;6:449\u201355.","journal-title":"World J Psychiatry."}],"container-title":["Current Psychiatry Reports"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s11920-019-1051-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s11920-019-1051-y\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s11920-019-1051-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,9,22]],"date-time":"2022-09-22T10:04:38Z","timestamp":1663841078000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s11920-019-1051-y"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,7,1]]},"references-count":77,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2019,8]]}},"alternative-id":["1051"],"URL":"https:\/\/doi.org\/10.1007\/s11920-019-1051-y","relation":{},"ISSN":["1523-3812","1535-1645"],"issn-type":[{"value":"1523-3812","type":"print"},{"value":"1535-1645","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,7,1]]},"assertion":[{"value":"1 July 2019","order":1,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with Ethical Standards"}},{"value":"Chlo\u00e9 Tezenas du Montcel, Franck Sch\u00fcrhoff, and Baptiste Pignon each declare no potential conflicts of interest.Antoine Pelissolo is a section editor for <i>Current Psychiatry Reports<\/i>.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of Interest"}},{"value":"This article does not contain any studies with human or animal subjects performed by any of the authors.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Human and Animal Rights and Informed Consent"}}],"article-number":"64"}}